163 related articles for article (PubMed ID: 28122154)
1. Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.
Shikata Y; Yoshimaru T; Komatsu M; Katoh H; Sato R; Kanagaki S; Okazaki Y; Toyokuni S; Tashiro E; Ishikawa S; Katagiri T; Imoto M
Cancer Sci; 2017 Apr; 108(4):785-794. PubMed ID: 28122154
[TBL] [Abstract][Full Text] [Related]
2. Xanthohumol impairs autophagosome maturation through direct inhibition of valosin-containing protein.
Sasazawa Y; Kanagaki S; Tashiro E; Nogawa T; Muroi M; Kondoh Y; Osada H; Imoto M
ACS Chem Biol; 2012 May; 7(5):892-900. PubMed ID: 22360440
[TBL] [Abstract][Full Text] [Related]
3. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.
Kunnimalaiyaan S; Trevino J; Tsai S; Gamblin TC; Kunnimalaiyaan M
Mol Cancer Ther; 2015 Jun; 14(6):1395-403. PubMed ID: 25887885
[TBL] [Abstract][Full Text] [Related]
4. Xanthohumol induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI3K/Akt/mTOR-kinase in human gastric cancer cells.
Guo D; Zhang B; Liu S; Jin M
Biomed Pharmacother; 2018 Oct; 106():1300-1306. PubMed ID: 30119200
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer.
Jiang W; Zhao S; Xu L; Lu Y; Lu Z; Chen C; Ni J; Wan R; Yang L
Biomed Pharmacother; 2015 Jul; 73():40-7. PubMed ID: 26211581
[TBL] [Abstract][Full Text] [Related]
6. Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells.
Sławińska-Brych A; Zdzisińska B; Dmoszyńska-Graniczka M; Jeleniewicz W; Kurzepa J; Gagoś M; Stepulak A
Toxicology; 2016 May; 357-358():65-73. PubMed ID: 27317025
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells.
Deeb D; Gao X; Jiang H; Arbab AS; Dulchavsky SA; Gautam SC
Anticancer Res; 2010 Sep; 30(9):3333-9. PubMed ID: 20944105
[TBL] [Abstract][Full Text] [Related]
8. Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma.
Kunnimalaiyaan S; Sokolowski KM; Balamurugan M; Gamblin TC; Kunnimalaiyaan M
PLoS One; 2015; 10(5):e0127464. PubMed ID: 26011160
[TBL] [Abstract][Full Text] [Related]
9. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
[TBL] [Abstract][Full Text] [Related]
10. Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro.
Wei S; Sun T; Du J; Zhang B; Xiang D; Li W
Oncol Rep; 2018 Dec; 40(6):3213-3222. PubMed ID: 30272303
[TBL] [Abstract][Full Text] [Related]
11. The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death.
Chen PH; Chang CK; Shih CM; Cheng CH; Lin CW; Lee CC; Liu AJ; Ho KH; Chen KC
Neuropharmacology; 2016 Nov; 110(Pt A):362-375. PubMed ID: 27487563
[TBL] [Abstract][Full Text] [Related]
12. Xanthohumol exhibits anti-myeloma activity in vitro through inhibition of cell proliferation, induction of apoptosis via the ERK and JNK-dependent mechanism, and suppression of sIL-6R and VEGF production.
Sławińska-Brych A; Zdzisińska B; Czerwonka A; Mizerska-Kowalska M; Dmoszyńska-Graniczka M; Stepulak A; Gagoś M
Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129408. PubMed ID: 31386885
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative and Cytotoxic Activity of Xanthohumol and Its Non-Estrogenic Derivatives in Colon and Hepatocellular Carcinoma Cell Lines.
Logan IE; Miranda CL; Lowry MB; Maier CS; Stevens JF; Gombart AF
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857300
[TBL] [Abstract][Full Text] [Related]
14. Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells.
Dokduang H; Yongvanit P; Namwat N; Pairojkul C; Sangkhamanon S; Yageta MS; Murakami Y; Loilome W
Oncol Rep; 2016 Apr; 35(4):2065-72. PubMed ID: 26794001
[TBL] [Abstract][Full Text] [Related]
15. Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation.
Gallo C; Dallaglio K; Bassani B; Rossi T; Rossello A; Noonan DM; D'Uva G; Bruno A; Albini A
Oncotarget; 2016 Sep; 7(37):59917-59931. PubMed ID: 27494895
[TBL] [Abstract][Full Text] [Related]
16. Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model.
Zhang W; Pan Y; Gou P; Zhou C; Ma L; Liu Q; Du Y; Yang J; Wang Q
Oncol Rep; 2018 Jan; 39(1):280-288. PubMed ID: 29138867
[TBL] [Abstract][Full Text] [Related]
17. Anticancer agent xanthohumol inhibits IL-2 induced signaling pathways involved in T cell proliferation.
Liu Y; Gao X; Deeb D; Arbab AS; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2012; 10(1):1-8. PubMed ID: 22946339
[TBL] [Abstract][Full Text] [Related]
18. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro.
Sławińska-Brych A; Król SK; Dmoszyńska-Graniczka M; Zdzisińska B; Stepulak A; Gagoś M
Chem Biol Interact; 2015 Oct; 240():110-8. PubMed ID: 26297991
[TBL] [Abstract][Full Text] [Related]
19. Valosin-containing protein (VCP) promotes the growth, invasion, and metastasis of colorectal cancer through activation of STAT3 signaling.
Fu Q; Jiang Y; Zhang D; Liu X; Guo J; Zhao J
Mol Cell Biochem; 2016 Jul; 418(1-2):189-98. PubMed ID: 27344168
[TBL] [Abstract][Full Text] [Related]
20. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells.
Colgate EC; Miranda CL; Stevens JF; Bray TM; Ho E
Cancer Lett; 2007 Feb; 246(1-2):201-9. PubMed ID: 16563612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]